{
    "xml": "<topic id=\"PHP4985\" outputclass=\"drug\" rev=\"1.14\" type=\"drug\" namespace=\"/drugs/intra-uterine-contraceptive-devices-copper\" basename=\"intra-uterine-contraceptive-devices-copper\" title=\"INTRA-UTERINE CONTRACEPTIVE DEVICES (COPPER)\">\n<title>INTRA-UTERINE CONTRACEPTIVE DEVICES (COPPER)</title>\n<body/>\n<topic id=\"PHP45784\" outputclass=\"indicationsAndDose\" rev=\"1.15\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Contraception</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intra-uterine administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45855\" outputclass=\"importantSafetyInformation\" rev=\"1.24\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">MHRA/CHM advice (June 2015) Intra-uterine contraception: uterine perforation&#8212;updated information on risk factors</p>\n<p>Uterine perforation most often occurs during insertion, but might not be detected until sometime later. The risk of uterine perforation is increased when the device is inserted up to 36 weeks postpartum or in patients who are breastfeeding. Before inserting an intra-uterine contraceptive device, inform patients that perforation occurs in approximately 1 in every 1000 insertions and signs and symptoms include:</p>\n<ul>\n<li>severe pelvic pain after insertion (worse than period cramps);</li>\n<li>pain or increased bleeding after insertion which continues for more than a few weeks;</li>\n<li>sudden changes in periods;</li>\n<li>pain during intercourse;</li>\n<li>unable to feel the threads.</li>\n</ul>\n<p>Patients should be informed on how to check their threads and to arrange a check-up if threads cannot be felt, especially if they also have significant pain. Partial perforation may occur even if the threads can be seen; consider this if there is severe pain following insertion and perform an ultrasound.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45875\" outputclass=\"contraindications\" rev=\"1.13\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Active trophoblastic disease (until return to normal of urine and plasma-gonadotrophin concentration)</ph>; <ph outputclass=\"contraindication\">distorted uterine cavity</ph>; <ph outputclass=\"contraindication\">established or marked immunosuppression</ph>; <ph outputclass=\"contraindication\">genital malignancy</ph>; <ph outputclass=\"contraindication\">medical diathermy</ph>; <ph outputclass=\"contraindication\">pelvic inflammatory disease</ph>; <ph outputclass=\"contraindication\">recent sexually transmitted infection (if not fully investigated and treated)</ph>; <ph outputclass=\"contraindication\">severe anaemia</ph>; <ph outputclass=\"contraindication\">small uterine cavity</ph>; <ph outputclass=\"contraindication\">unexplained uterine bleeding</ph>; <ph outputclass=\"contraindication\">Wilson&#8217;s disease</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45906\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Anaemia</ph>; <ph outputclass=\"caution\">anticoagulant therapy (avoid if possible)</ph>; <ph outputclass=\"caution\">diabetes</ph>; <ph outputclass=\"caution\">disease-induced immunosuppression (risk of infection&#8212;avoid if marked immunosuppression)</ph>; <ph outputclass=\"caution\">drug-induced immunosuppression (risk of infection&#8212;avoid if marked immunosuppression)</ph>; <ph outputclass=\"caution\">endometriosis</ph>; <ph outputclass=\"caution\">epilepsy (risk of seizure at time of insertion)</ph>; <ph outputclass=\"caution\">fertility problems</ph>; <ph outputclass=\"caution\">history of pelvic inflammatory disease</ph>; <ph outputclass=\"caution\">increased risk of expulsion if inserted before uterine involution</ph>; <ph outputclass=\"caution\">menorrhagia (progestogen intra-uterine system might be preferable)</ph>; <ph outputclass=\"caution\">nulliparity</ph>; <ph outputclass=\"caution\">severe cervical stenosis</ph>; <ph outputclass=\"caution\">severe primary dysmenorrhoea</ph>; <ph outputclass=\"caution\">severely scarred uterus (including after endometrial resection)</ph>; <ph outputclass=\"caution\">young age</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Risk of infection</p>\n<p>The main excess risk of infection occurs in the first 20 days after insertion and is believed to be related to existing carriage of a sexually transmitted infection. Women are considered to be at a higher risk of sexually transmitted infections if:</p>\n<ul>\n<li> they are under 25 years old <i>or</i>\n</li>\n<li>they are over 25 years old <i>and</i>\n</li>\n<li>\n<ul>\n<li>have a new partner <i>or</i>\n</li>\n<li>have had more than one partner in the past year <i>or</i>\n</li>\n<li>their regular partner has other partners.</li>\n</ul>\n</li>\n</ul>\n<p>In these women, pre-insertion screening (for chlamydia and, depending on sexual history and local prevalence of disease, <ph outputclass=\"organism\">\n<i>Neisseria gonorrhoeae</i>\n</ph>) should be performed. If results are unavailable at the time of fitting an intrauterine device for emergency contraception, appropriate prophylactic antibacterial cover should be given. The woman should be advised to attend <i>as an emergency</i> if she experiences sustained pain during the next 20 days.</p>\n<p>An intra-uterine device should not be removed in mid-cycle unless an additional contraceptive was used for the previous 7 days. If removal is essential post-coital contraception should be considered.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45692\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Allergy</ph>; <ph outputclass=\"sideEffect\">bleeding (on insertion)</ph>; <ph outputclass=\"sideEffect\">cervical perforation</ph>; <ph outputclass=\"sideEffect\">displacement</ph>; <ph outputclass=\"sideEffect\">dysmenorrhoea</ph>; <ph outputclass=\"sideEffect\">expulsion</ph>; <ph outputclass=\"sideEffect\">menorrhagia</ph>; <ph outputclass=\"sideEffect\">occasionally epileptic seizure (on insertion)</ph>; <ph outputclass=\"sideEffect\">pain (on insertion, alleviated by NSAID such as ibuprofen 30 minutes before insertion)</ph>; <ph outputclass=\"sideEffect\">pelvic infection may be exacerbated</ph>; <ph outputclass=\"sideEffect\">uterine perforation</ph>; <ph outputclass=\"sideEffect\">vasovagal attack (on insertion)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Presence of significant symptoms (especially pain)</p>\n<p>Advise the patient to seek medical attention promptly in case of significant symptoms.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45929\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.16\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Allergy and cross-sensitivity</title>\n<body>\n<section outputclass=\"allergyAndCrossSensitivityContraindications\">\n<sectiondiv>\n<p>Contraindicated if patient has a copper allergy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45743\" outputclass=\"pregnancy\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>If an intra-uterine device fails and the woman wishes to continue to full-term the device should be removed in the first trimester if possible.</p>\n<p>Remove device; if pregnancy occurs, increased likelihood that it may be ectopic.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45922\" outputclass=\"breastFeeding\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Not known to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45661\" outputclass=\"monitoringRequirements\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Gynaecological examination before insertion, 6&#8211;8 weeks after insertion, then annually.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45941\" outputclass=\"directionsForAdministration\" rev=\"1.8\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>The timing and technique of fitting an intra-uterine device are critical for its subsequent performance. <i>The healthcare professional inserting (or removing) the device should be fully trained in the technique and should provide full counselling backed, where available, by the patient information leaflet.</i> Devices should not be fitted during the heavy days of the period; they are best fitted after the end of menstruation and before the calculated time of implantation.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4985-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/intra-uterine-contraceptive-devices-copper\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP105341\" title=\"Products without form\" namespace=\"/drugs/intra-uterine-contraceptive-devices-copper/products-without-form\">Products without form</xref>\n</children>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP105341\" namespace=\"/drugs/intra-uterine-contraceptive-devices-copper/products-without-form\" title=\"Products without form\" count=\"1\" rel=\"link\">Products without form</xref>\n</links>\n</topic>",
    "id": "PHP4985",
    "outputclass": "drug",
    "rev": "1.14",
    "type": "drug",
    "namespace": "/drugs/intra-uterine-contraceptive-devices-copper",
    "basename": "intra-uterine-contraceptive-devices-copper",
    "title": "INTRA-UTERINE CONTRACEPTIVE DEVICES (COPPER)",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Contraception",
                        "html": "Contraception"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intra-uterine administration"
                    ],
                    "textContent": "By intra-uterine administration",
                    "html": "By intra-uterine administration"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>",
                        "ageGroup": "females of childbearing potential"
                    }
                ]
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "title": "MHRA/CHM advice (June 2015) Intra-uterine contraception: uterine perforation&#8212;updated information on risk factors",
                "textContent": "Uterine perforation most often occurs during insertion, but might not be detected until sometime later. The risk of uterine perforation is increased when the device is inserted up to 36 weeks postpartum or in patients who are breastfeeding. Before inserting an intra-uterine contraceptive device, inform patients that perforation occurs in approximately 1 in every 1000 insertions and signs and symptoms include:\n\nsevere pelvic pain after insertion (worse than period cramps); pain or increased bleeding after insertion which continues for more than a few weeks; sudden changes in periods; pain during intercourse; unable to feel the threads.\n\nPatients should be informed on how to check their threads and to arrange a check-up if threads cannot be felt, especially if they also have significant pain. Partial perforation may occur even if the threads can be seen; consider this if there is severe pain following insertion and perform an ultrasound.",
                "html": "<p>Uterine perforation most often occurs during insertion, but might not be detected until sometime later. The risk of uterine perforation is increased when the device is inserted up to 36 weeks postpartum or in patients who are breastfeeding. Before inserting an intra-uterine contraceptive device, inform patients that perforation occurs in approximately 1 in every 1000 insertions and signs and symptoms include:</p><ul>\n<li>severe pelvic pain after insertion (worse than period cramps);</li>\n<li>pain or increased bleeding after insertion which continues for more than a few weeks;</li>\n<li>sudden changes in periods;</li>\n<li>pain during intercourse;</li>\n<li>unable to feel the threads.</li>\n</ul><p>Patients should be informed on how to check their threads and to arrange a check-up if threads cannot be felt, especially if they also have significant pain. Partial perforation may occur even if the threads can be seen; consider this if there is severe pain following insertion and perform an ultrasound.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Active trophoblastic disease (until return to normal of urine and plasma-gonadotrophin concentration)",
                "html": "Active trophoblastic disease (until return to normal of urine and plasma-gonadotrophin concentration)"
            },
            {
                "type": "contraindications",
                "textContent": "distorted uterine cavity",
                "html": "distorted uterine cavity"
            },
            {
                "type": "contraindications",
                "textContent": "established or marked immunosuppression",
                "html": "established or marked immunosuppression"
            },
            {
                "type": "contraindications",
                "textContent": "genital malignancy",
                "html": "genital malignancy"
            },
            {
                "type": "contraindications",
                "textContent": "medical diathermy",
                "html": "medical diathermy"
            },
            {
                "type": "contraindications",
                "textContent": "pelvic inflammatory disease",
                "html": "pelvic inflammatory disease"
            },
            {
                "type": "contraindications",
                "textContent": "recent sexually transmitted infection (if not fully investigated and treated)",
                "html": "recent sexually transmitted infection (if not fully investigated and treated)"
            },
            {
                "type": "contraindications",
                "textContent": "severe anaemia",
                "html": "severe anaemia"
            },
            {
                "type": "contraindications",
                "textContent": "small uterine cavity",
                "html": "small uterine cavity"
            },
            {
                "type": "contraindications",
                "textContent": "unexplained uterine bleeding",
                "html": "unexplained uterine bleeding"
            },
            {
                "type": "contraindications",
                "textContent": "Wilson&#8217;s disease",
                "html": "Wilson&#8217;s disease"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Anaemia",
                "html": "Anaemia"
            },
            {
                "type": "cautions",
                "textContent": "anticoagulant therapy (avoid if possible)",
                "html": "anticoagulant therapy (avoid if possible)"
            },
            {
                "type": "cautions",
                "textContent": "diabetes",
                "html": "diabetes"
            },
            {
                "type": "cautions",
                "textContent": "disease-induced immunosuppression (risk of infection&#8212;avoid if marked immunosuppression)",
                "html": "disease-induced immunosuppression (risk of infection&#8212;avoid if marked immunosuppression)"
            },
            {
                "type": "cautions",
                "textContent": "drug-induced immunosuppression (risk of infection&#8212;avoid if marked immunosuppression)",
                "html": "drug-induced immunosuppression (risk of infection&#8212;avoid if marked immunosuppression)"
            },
            {
                "type": "cautions",
                "textContent": "endometriosis",
                "html": "endometriosis"
            },
            {
                "type": "cautions",
                "textContent": "epilepsy (risk of seizure at time of insertion)",
                "html": "epilepsy (risk of seizure at time of insertion)"
            },
            {
                "type": "cautions",
                "textContent": "fertility problems",
                "html": "fertility problems"
            },
            {
                "type": "cautions",
                "textContent": "history of pelvic inflammatory disease",
                "html": "history of pelvic inflammatory disease"
            },
            {
                "type": "cautions",
                "textContent": "increased risk of expulsion if inserted before uterine involution",
                "html": "increased risk of expulsion if inserted before uterine involution"
            },
            {
                "type": "cautions",
                "textContent": "menorrhagia (progestogen intra-uterine system might be preferable)",
                "html": "menorrhagia (progestogen intra-uterine system might be preferable)"
            },
            {
                "type": "cautions",
                "textContent": "nulliparity",
                "html": "nulliparity"
            },
            {
                "type": "cautions",
                "textContent": "severe cervical stenosis",
                "html": "severe cervical stenosis"
            },
            {
                "type": "cautions",
                "textContent": "severe primary dysmenorrhoea",
                "html": "severe primary dysmenorrhoea"
            },
            {
                "type": "cautions",
                "textContent": "severely scarred uterus (including after endometrial resection)",
                "html": "severely scarred uterus (including after endometrial resection)"
            },
            {
                "type": "cautions",
                "textContent": "young age",
                "html": "young age"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Risk of infection",
                "textContent": "The main excess risk of infection occurs in the first 20 days after insertion and is believed to be related to existing carriage of a sexually transmitted infection. Women are considered to be at a higher risk of sexually transmitted infections if:\n\nthey are under 25 years old or they are over 25 years old and have a new partner or have had more than one partner in the past year or their regular partner has other partners.\n\nIn these women, pre-insertion screening (for chlamydia and, depending on sexual history and local prevalence of disease, Neisseria gonorrhoeae ) should be performed. If results are unavailable at the time of fitting an intrauterine device for emergency contraception, appropriate prophylactic antibacterial cover should be given. The woman should be advised to attend as an emergency if she experiences sustained pain during the next 20 days.\n\nAn intra-uterine device should not be removed in mid-cycle unless an additional contraceptive was used for the previous 7 days. If removal is essential post-coital contraception should be considered.",
                "html": "<p>The main excess risk of infection occurs in the first 20 days after insertion and is believed to be related to existing carriage of a sexually transmitted infection. Women are considered to be at a higher risk of sexually transmitted infections if:</p><ul>\n<li> they are under 25 years old <i>or</i>\n</li>\n<li>they are over 25 years old <i>and</i>\n</li>\n<li>\n<ul>\n<li>have a new partner <i>or</i>\n</li>\n<li>have had more than one partner in the past year <i>or</i>\n</li>\n<li>their regular partner has other partners.</li>\n</ul>\n</li>\n</ul><p>In these women, pre-insertion screening (for chlamydia and, depending on sexual history and local prevalence of disease, <ph outputclass=\"organism\">\n<i>Neisseria gonorrhoeae</i>\n</ph>) should be performed. If results are unavailable at the time of fitting an intrauterine device for emergency contraception, appropriate prophylactic antibacterial cover should be given. The woman should be advised to attend <i>as an emergency</i> if she experiences sustained pain during the next 20 days.</p><p>An intra-uterine device should not be removed in mid-cycle unless an additional contraceptive was used for the previous 7 days. If removal is essential post-coital contraception should be considered.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Allergy",
                        "html": "Allergy",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bleeding (on insertion)",
                        "html": "bleeding (on insertion)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "cervical perforation",
                        "html": "cervical perforation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "displacement",
                        "html": "displacement",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dysmenorrhoea",
                        "html": "dysmenorrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "expulsion",
                        "html": "expulsion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "menorrhagia",
                        "html": "menorrhagia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "occasionally epileptic seizure (on insertion)",
                        "html": "occasionally epileptic seizure (on insertion)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pain (on insertion, alleviated by NSAID such as ibuprofen 30 minutes before insertion)",
                        "html": "pain (on insertion, alleviated by NSAID such as ibuprofen 30 minutes before insertion)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pelvic infection may be exacerbated",
                        "html": "pelvic infection may be exacerbated",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "uterine perforation",
                        "html": "uterine perforation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vasovagal attack (on insertion)",
                        "html": "vasovagal attack (on insertion)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Presence of significant symptoms (especially pain)",
                "textContent": "Advise the patient to seek medical attention promptly in case of significant symptoms.",
                "html": "<p>Advise the patient to seek medical attention promptly in case of significant symptoms.</p>"
            }
        ]
    },
    "allergyAndCrossSensitivity": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Contraindicated if patient has a copper allergy.",
                "html": "<p>Contraindicated if patient has a copper allergy.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "If an intra-uterine device fails and the woman wishes to continue to full-term the device should be removed in the first trimester if possible.\n\nRemove device; if pregnancy occurs, increased likelihood that it may be ectopic.",
                "html": "<p>If an intra-uterine device fails and the woman wishes to continue to full-term the device should be removed in the first trimester if possible.</p><p>Remove device; if pregnancy occurs, increased likelihood that it may be ectopic.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Not known to be harmful.",
                "html": "<p>Not known to be harmful.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Gynaecological examination before insertion, 6&#8211;8 weeks after insertion, then annually.",
                "html": "<p>Gynaecological examination before insertion, 6&#8211;8 weeks after insertion, then annually.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "The timing and technique of fitting an intra-uterine device are critical for its subsequent performance. The healthcare professional inserting (or removing) the device should be fully trained in the technique and should provide full counselling backed, where available, by the patient information leaflet. Devices should not be fitted during the heavy days of the period; they are best fitted after the end of menstruation and before the calculated time of implantation.",
                "html": "<p>The timing and technique of fitting an intra-uterine device are critical for its subsequent performance. <i>The healthcare professional inserting (or removing) the device should be fully trained in the technique and should provide full counselling backed, where available, by the patient information leaflet.</i> Devices should not be fitted during the heavy days of the period; they are best fitted after the end of menstruation and before the calculated time of implantation.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP105341",
                "label": "Products without form",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP105341",
                "label": "Products without form",
                "type": "medicinalForm"
            }
        ]
    }
}